Table 3 Re-classification of histotypes
From: Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
Original classification: | Revised Classification | Total original | |||||||
|---|---|---|---|---|---|---|---|---|---|
BOT | HGSC | EC | LGSC | CCC | MC | other | unknown | ||
HGSC | 1 | 1131 (95%) | 14 | 30 | 9 | 2 | 3 | 1 | 1191 |
EC | 1 | 43 | 267 (84%) | 0 | 0 | 2 | 3 | 1 | 317 |
LGSC | 9 | 19 | 0 | 69 (72%) | 0 | 0 | 0 | 0 | 96 |
CCC | 1 | 4 | 4 | 0 | 248 (96%) | 0 | 0 | 0 | 257 |
MC | 10 | 6 | 10 | 0 | 0 | 84 (73%) | 6 | 0 | 116 |
other | 1 | 7 | 1 | 1 | 1 | 0 | 11(55%) | 0 | 20 |
unknown | 2 | 36 | 0 | 3 | 1 | 0 | 0 | 6 (NA) | 48 |
Total after reclassification | 25 | 1246 | 296 | 102 | 259 | 88 | 21 | 8 | 2045 |